Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sutro Biopharma Inc

0.8480
+0.02372.88%
Post-market: 0.85000.0020+0.24%19:33 EDT
Volume:632.00K
Turnover:540.90K
Market Cap:71.62M
PE:-0.28
High:0.8794
Open:0.8336
Low:0.8201
Close:0.8243
Loading ...
May 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2024

Major Issues Report

Form 8-K - Current report
Apr 05, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 02, 2024

Major Issues Report

Form 8-K - Current report
Apr 02, 2024

Major Issues Report

Form 8-K - Current report
Mar 25, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 25, 2024

Major Issues Report

Form 8-K - Current report
Feb 27, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 09, 2024

Major Issues Report

Form 8-K - Current report
Feb 07, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 18, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Nov 28, 2023

Major Issues Report

Form 8-K - Current report
Nov 21, 2023

Major Issues Report

Form 8-K - Current report
Nov 18, 2023

Correspondence

Form CORRESP - Correspondence
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]